Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders

Frontiers in Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Vadnie, Chelsea A ^a,b   Park, Jun Hyun ^a,c   Gawad, Noha Abdel ^b   Ho, Ada Man Choi ^a,b   Hinton, David J ^a,b   Choi, Doo Sup ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c Inje University College of Medicine   (South Korea)

Author keywords

Alcohol; GLP 1; Neurotensin; NPY; peptide; Substance P

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRUGS USED IN THE TREATMENT OF ADDICTION; EZLOPITANT; GHRELIN; GHRELIN RECEPTOR ANTAGONIST; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HORMONE RECEPTOR BLOCKING AGENT; JMV 2959; L 822429; NEUROPEPTIDE Y; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; SUBSTANCE P; TRADIPITANT; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL USE DISORDER; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANTICIPATION; BINGE DRINKING; BRAIN CORTEX; BRAIN NERVE CELL; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MOTIVATION; NERVE PROJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; REINFORCEMENT; REVIEW; REWARD; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

EID: 84907938728     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00288     Document Type: Review

References (321)

1. Abizaid, A., Liu, Z.-W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., et al. (2006). Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116, 3229-3239. doi: 10.1172/JCI29867
2. Addolorato, G., Capristo, E., Leggio, L., Ferrulli, A., Abenavoli, L., Malandrino, N., et al. (2006). Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol. Clin. Exp. Res. 30, 1933-1937. doi: 10.1111/j.1530-0277.2006.00238.x
3. Agrawal, A., Lynskey, M. T., Todorov, A. A., Schrage, A. J., Littlefield, A. K., Grant, J. D., et al. (2011). A candidate gene association study of alcohol consumption in young women. Alcohol. Clin. Exp. Res. 35, 550-558. doi: 10.1111/j.1530-0277.2010.01372.x
4. Alexander, M. J., and Leeman, S. E. (1998). Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor. J. Comp. Neurol. 402, 475-500. doi: 10.1002/(SICI)1096-9861(19981228)402:4<475::AID-CNE4>3.0.CO;2-9
5. Alhadeff, A. L., Rupprecht, L. E., and Hayes, M. R. (2012). GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153, 647-658. doi: 10.1210/en.2011-1443
6. Alvarez-Crespo, M., Skibicka, K. P., Farkas, I., Molnar, C. S., Egecioglu, E., Hrabovszky, E., et al. (2012). The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PLoS ONE 7:e46321. doi: 10.1371/journal.pone.0046321
7. Anderberg, R. H., Anefors, C., Bergquist, F., Nissbrandt, H., and Skibicka, K. P. (2014). Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior. Physiol. Behav. doi: 10.1016/j.physbeh.2014.02.026. [Epub ahead of print].
8. Arnold, M., Mura, A., Langhans, W., and Geary, N. (2006). Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J. Neurosci. 26, 11052-11060. doi: 10.1523/JNEUROSCI.2606-06.2006
9. Badaoui, A., De Saeger, C., Duchemin, J., Gihousse, D., de Timary, P., and Stärkel, P. (2008). Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. Eur. J. Clin. Invest. 38, 397-403. doi: 10.1111/j.1365-2362.2008.01947.x
10. Badia-Elder, N. E., Gilpin, N. W., and Stewart, R. B. (2007). Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background. Peptides 28, 339-344. doi: 10.1016/j.peptides.2006.07.028
11. Badia-Elder, N. E., Stewart, R. B., Powrozek, T. A., Murphy, J. M., and Li, T. K. (2003). Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Alcohol. Clin. Exp. Res. 27, 894-899. doi: 10.1111/j.1530-0277.2003.tb04413.x
12. Badia-Elder, N. E., Stewart, R. B., Powrozek, T. A., Roy, K. F., Murphy, J. M., and Li, T. K. (2001). Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol. Clin. Exp. Res. 25, 386-390. doi: 10.1111/j.1530-0277.2001.tb02225.x
13. Bahi, A., Tolle, V., Fehrentz, J.-A., Brunel, L., Martinez, J., Tomasetto, C.-L., et al. (2013). Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides 43, 48-55. doi: 10.1016/j.peptides.2013.02.008
14. Banks, W. A., Tschop, M., Robinson, S. M., and Heiman, M. L. (2002). Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302, 822-827. doi: 10.1124/jpet.102.034827
15. Barnes, J. M., Barnes, N. M., Costall, B., Cox, A. J., Domeney, A. M., Kelly, M. E., et al. (1990). Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area. Pharmacol. Biochem. Behav. 37, 839-841. doi: 10.1016/0091-3057(90)90572-Y
16. Bauer, J., Pedersen, A., Scherbaum, N., Bening, J., Patschke, J., Kugel, H., et al. (2013). Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacology 38, 1401-1408. doi: 10.1038/npp.2013.45
17. Belknap, J. K., Crabbe, J. C., and Young, E. R. (1993). Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112, 503-510. doi: 10.1007/BF02244901
18. Bell, R. L., Rodd, Z. A., Lumeng, L., Murphy, J. M., and McBride, W. J. (2006). The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict. Biol. 11, 270-288. doi: 10.1111/j.1369-1600.2005.00029.x
19. Bennett, B., Carosone-Link, P., Zahniser, N. R., and Johnson, T. E. (2006). Confirmation and fine mapping of ethanol sensitivity quantitative trait loci, and candidate gene testing in the LXS recombinant inbred mice. J. Pharm. Exp. Ther. 319, 299-307. doi: 10.1124/jpet.106.103572
20. Bertilsson, G., Patrone, C., Zachrisson, O., Andersson, A., Dannaeus, K., Heidrich, J., et al. (2008). Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease. J. Neurosci. Res. 86, 326-338. doi: 10.1002/jnr.21483
21. Bhaskar, L. V., Thangaraj, K., Kumar, K. P., Pardhasaradhi, G., Singh, L., and Rao, V. R. (2013). Association between neuropeptide Y gene polymorphisms and alcohol dependence: a case-control study in two independent populations. Eur. Addict. Res. 19, 307-313. doi: 10.1159/000346679
22. Binder, E. B., Kinkead, B., Owens, M. J., and Nemeroff, C. B. (2001a). Neurotensin and dopamine interactions. Pharmacol. Rev. 53, 453-486.
23. Binder, E. B., Kinkead, B., Owens, M. J., and Nemeroff, C. B. (2001b). The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol. Psychiatry 50, 856-872. doi: 10.1016/S0006-3223(01)01211-2
24. Bissette, G., Nemeroff, C. B., Loosen, P. T., Prange, A. J. Jr., and Lipton, M. A. (1976). Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature 262, 607-609. doi: 10.1038/262607a0
25. Blaine, S., Claus, E., Harlaar, N., and Hutchison, K. (2013). TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol. Clin. Exp. Res. 37(Suppl. 1), E125-E130. doi: 10.1111/j.1530-0277.2012.01923.x
26. Blomqvist, A. G., and Herzog, H. (1997). Y-receptor subtypes-how many more? Trends Neurosci. 20, 294-298. doi: 10.1016/S0166-2236(96)01057-0
27. Boix, F., Mattioli, R., Adams, F., Huston, J. P., and Schwarting, R. K. (1992). Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens. Eur. J. Pharmacol. 216, 103-107. doi: 10.1016/0014-2999(92)90215-P
28. Borroto-Escuela, D. O., Ravani, A., Tarakanov, A. O., Brito, I., Narvaez, M., Romero-Fernandez, W., et al. (2013). Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. Biochem. Biophys. Res. Commun. 435, 140-146. doi: 10.1016/j.bbrc.2013.04.058
29. Boudin, H., Pelaprat, D., Rostene, W., and Beaudet, A. (1996). Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373, 76-89. doi: 10.1002/(SICI)1096-9861(19960909)373:1<76::AID-CNE7>3.0.CO;2-A
30. Boules, M., Fredrickson, P., and Richelson, E. (2006). Bioactive analogs of neurotensin: focus on CNS effects. Peptides 27, 2523-2533. doi: 10.1016/j.peptides.2005.12.018
31. Boules, M., Li, Z., Smith, K., Fredrickson, P., and Richelson, E. (2013). Diverse roles of neurotensin agonists in the central nervous system. Front. Endocrinol (Lausanne) 4:36. doi: 10.3389/fendo.2013.00036
32. Boules, M., Liang, Y., Briody, S., Miura, T., Fauq, I., Oliveros, A., et al. (2010). NT79: a novel neurotensin analog with selective behavioral effects. Brain Res. 1308, 35-46. doi: 10.1016/j.brainres.2009.10.050
33. Bulik, C. M., Klump, K. L., Thornton, L., Kaplan, A. S., Devlin, B., Fichter, M. M., et al. (2004). Alcohol use disorder comorbidity in eating disorders: a multicenter study. J. Clin. Psychiatry 65, 1000-1006. doi: 10.4088/JCP.v65n0718
34. Burgevin, M. C., Laduron, P. M., Quarteronnet, D., Chevet, T., and Castel, M. N. (1992). Striatal injection of neurotensin increases tyrosine hydroxylase mRNA in substantia nigra. Ann. N.Y. Acad. Sci. 668, 311-313. doi: 10.1111/j.1749-6632.1992.tb27360.x
35. Caberlotto, L., Fuxe, K., Rimland, J. M., Sedvall, G., and Hurd, Y. L. (1998). Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience 86, 167-178. doi: 10.1016/S0306-4522(98)00039-6
36. Calissendorff, J., Danielsson, O., Brismar, K., and Röjdmark, S. (2005). Inhibitory effect of alcohol on ghrelin secretion in normal man. Eur. J. Endocrinol. 152, 743-747. doi: 10.1530/eje.1.01905
37. Calissendorff, J., Danielsson, O., Brismar, K., and Röjdmark, S. (2006). Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects. Metabolism 55, 1625-1629. doi: 10.1016/j.metabol.2006.08.003
38. Campbell, A. D., and Gene Erwin, V. (1993). Chronic ethanol administration downregulates neurotensin receptors in long-and short-sleep mice. Pharmacol. Biochem. Behav. 45, 95-106. doi: 10.1016/0091-3057(93)90092-8
39. Carr, L. G., Foroud, T., Bice, P., Gobbett, T., Ivashina, J., Edenberg, H., et al. (1998). A quantitative trait locus for alcohol consumption in selectively bred rat lines. Alcohol. Clin. Exp. Res. 22, 884-887. doi: 10.1111/j.1530-0277.1998.tb03883.x
40. Carr, L. G., Habegger, K., Spence, J. P., Liu, L., Lumeng, L., and Foroud, T. (2006). Development of congenic rat strains for alcohol consumption derived from the alcohol-preferring and nonpreferring rats. Behav. Genet. 36, 285-290. doi: 10.1007/s10519-005-9021-z
41. Carraway, R., and Leeman, S. E. (1973). The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248, 6854-6861.
42. Chapman, M. A., See, R. E., and Bissette, G. (1992). Neurotensin increases extracellular striatal dopamine levels in vivo. Neuropeptides 22, 175-183. doi: 10.1016/0143-4179(92)90160-X
43. Chen, J., Nam, H. W., Lee, M. R., Hinton, D. J., Choi, S., Kim, T., et al. (2010). Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behav. Brain Res. 208, 636-642. doi: 10.1016/j.bbr.2010.01.011
44. Chen, X., Dimaggio, D. A., Han, S. P., and Westfall, T. C. (1997). Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. Am. J. Physiol. 273, H1737-H1744. doi: 10.1152/ajpheart.00135.2013
45. Cippitelli, A., Rezvani, A. H., Robinson, J. E., Eisenberg, L., Levin, E. D., Bonaventure, P., et al. (2011). The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety. Alcohol 45, 567-576. doi: 10.1016/j.alcohol.2010.09.003
46. Cooke, J. H., Patterson, M., Patel, S. R., Smith, K. L., Ghatei, M. A., Bloom, S. R., et al. (2009). Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) 17, 1135-1143. doi: 10.1038/oby.2008.652
47. Crabbe, J. C., Gray, D. K., Young, E. R., Janowsky, J. S., and Rigter, H. (1981). Initial sensitivity and tolerance to ethanol in mice: correlations among open field activity, hypothermia, and loss of righting reflex. Behav. Neural Biol. 33, 188-203. doi: 10.1016/S0163-1047(81)91625-3
48. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., and Weigle, D. S. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719. doi: 10.2337/diabetes.50.8.1714
49. Cunningham, C. L. (1995). Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology 120, 28-41. doi: 10.1007/BF02246142
50. Cunningham, C. L., Gremel, C. M., and Groblewski, P. A. (2006). Drug-induced conditioned place preference and aversion in mice. Nat. Protoc. 1, 1662-1670. doi: 10.1038/nprot.2006.279
51. Dansky, B. S., Brewerton, T. D., and Kilpatrick, D. G. (2000). Comorbidity of bulimia nervosa and alcohol use disorders: results from the national women's study. Int. J. Eat. Disord. 27, 180-190. doi: 10.1002/(SICI)1098-08X(200003)27:2<180::AID-EAT6>3.0.CO;2-Z
52. Dar, M. S. (1996). Mouse cerebellar GABAB participation in the expression of acute ethanol-induced ataxia and in its modulation by the cerebellar adenosinergic A1 system. Brain Res. Bull. 41, 53-59. doi: 10.1016/0361-9230(96)00172-4
53. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., et al. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120-1128. doi: 10.1053/gast.2002.35954
54. Davis, J. F., Schurdak, J. D., Magrisso, I. J., Mul, J. D., Grayson, B. E., Pfluger, P. T., et al. (2012). Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats. Biol. Psychiatry 72, 354-360. doi: 10.1016/j.biopsych.2012.01.035
55. de Timary, P., Cani, P. D., Duchemin, J., Neyrinck, A. M., Gihousse, D., Laterre, P. F., et al. (2012). The loss of metabolic control on alcohol drinking in heavy drinking alcohol-dependent subjects. PLoS ONE 7:e38682. doi: 10.1371/journal.pone.0038682
56. Deutch, A. Y., Maggio, J. E., Bannon, M. J., Kalivas, P. W., Tam, S. Y., Goldstein, M., et al. (1985). Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides 6(Suppl. 2), 113-122. doi: 10.1016/0196-9781(85)90143-3
57. Dickson, S. L., Egecioglu, E., Landgren, S., Skibicka, K. P., Engel, J. A., and Jerlhag, E. (2011). The role of the central ghrelin system in reward from food and chemical drugs. Mol. Cell. Endocrinol. 340, 80-87. doi: 10.1016/j.mce.2011.02.017
58. Dickson, S. L., Hrabovszky, E., Hansson, C., Jerlhag, E., Alvarez-Crespo, M., Skibicka, K. P., et al. (2010). Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience 171, 1180-1186. doi: 10.1016/j.neuroscience.2010.10.005
59. Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., and Skibicka, K. P. (2012). The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J. Neurosci. 32, 4812-4820. doi: 10.1523/JNEUROSCI.6326-11.2012
60. Disse, E., Bussier, A. L., Deblon, N., Pfluger, P. T., Tschop, M. H., Laville, M., et al. (2011). Systemic ghrelin and reward: effect of cholinergic blockade. Physiol. Behav. 102, 481-484. doi: 10.1016/j.physbeh.2010.12.006
61. Dossat, A. M., Lilly, N., Kay, K., and Williams, D. L. (2011). Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 31, 14453-14457. doi: 10.1523/JNEUROSCI.3262-11.2011
62. Dubuc, I., Costentin, J., Terranova, J. P., Barnouin, M. C., Soubrie, P., Le Fur, G., et al. (1994). The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br. J. Pharmacol. 112, 352-354. doi: 10.1111/j.1476-5381.1994.tb13077.x
63. During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., et al. (2003). Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9, 1173-1179. doi: 10.1038/nm919
64. Ebner, K., Rupniak, N. M., Saria, A., and Singewald, N. (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc. Natl. Acad. Sci. U.S.A. 101, 4280-4285. doi: 10.1073/pnas.0400794101
65. Egecioglu, E., Engel, J. A., and Jerlhag, E. (2013). The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS ONE 8:e69010. doi: 10.1371/journal.pone.0069010
66. Egecioglu, E., Jerlhag, E., Salome, N., Skibicka, K. P., Haage, D., Bohlooly, Y. M., et al. (2010). Ghrelin increases intake of rewarding food in rodents. Addict. Biol. 15, 304-311. doi: 10.1111/j.1369-1600.2010.00216.x
67. Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., and Jerlhag, E. (2012). The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 38, 1259-1270. doi: 10.1016/j.psyneuen.2012.11.009
68. Ehlers, C. L., Li, T. K., Lumeng, L., Hwang, B. H., Somes, C., Jimenez, P., et al. (1998). Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol. Clin. Exp. Res. 22, 1778-1782. doi: 10.1111/j.1530-0277.1998.tb03979.x
69. Ehlers, C. L., Somes, C., Li, T. K., Lumeng, L., Kinkead, B., Owens, M. J., et al. (1999). Neurotensin studies in alcohol naive, preferring and non-preferring rats. Neuroscience 93, 227-236. doi: 10.1016/S0306-4522(99)00113-X
70. Elliott, P. J., Alpert, J. E., Bannon, M. J., and Iversen, S. D. (1986). Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res. 363, 145-147. doi: 10.1016/0006-8993(86)90667-0
71. Elliott, P. J., Mason, G. S., Stephens-Smith, M., and Hagan, R. M. (1991). Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides 19, 119-126. doi: 10.1016/0143-4179(91)90141-5
72. Erreger, K., Davis, A. R., Poe, A. M., Greig, N. H., Stanwood, G. D., and Galli, A. (2012). Exendin-4 decreases amphetamine-induced locomotor activity. Physiol. Behav. 106, 574-578. doi: 10.1016/j.physbeh.2012.03.014
73. Ervin, G. N., Birkemo, L. S., Nemeroff, C. B., and Prange, A. J. (1981). Neurotensin blocks certain amphetamine-induced behaviours. Nature 291, 73-76. doi: 10.1038/291073a0
74. Erwin, V., Campbell, A. D., Myers, R., and Womer, D. E. (1995). Cross-tolerance between ethanol and neurotensin in mice selectively bred for ethanol sensitivity. Pharmacol. Biochem. Behav. 51, 891-899. doi: 10.1016/0091-3057(95)00070-D
75. Erwin, V. G., Gehle, V. M., Davidson, K., and Radcliffe, R. A. (2001). Confirmation of correlations and common quantitative trait loci between neurotensin receptor density and hypnotic sensitivity to ethanol. Alcohol. Clin. Exp. Res. 25, 1699-1707. doi: 10.1111/j.1530-0277.2001.tb02178.x
76. Erwin, V. G., and Jones, B. C. (1989). Comparison of neurotensin levels, receptors and actions in LS/Ibg and SS/Ibg mice. Peptides 10, 435-440. doi: 10.1016/0196-9781(89)90055-7
77. Erwin, V. G., and Jones, B. C. (1993). Genetic correlations among ethanol-related behaviors and neurotensin receptors in long sleep (LS) x short sleep (SS) recombinant inbred strains of mice. Behav. Genet. 23, 191-196. doi: 10.1007/BF01067424
78. Erwin, V. G., Jones, B. C., and Radcliffe, R. (1990). Low doses of ethanol reduce neurotensin levels in discrete brain regions from LS/Ibg and SS/Ibg mice. Alcohol. Clin. Exp. Res. 14, 42-47. doi: 10.1111/j.1530-0277.1990.tb00444.x
79. Everitt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., and Robbins, T. W. (2008). Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Phil. Trans. R. Soc. B. Biol. Sci. 363, 3125-3135. doi: 10.1098/rstb.2008.0089
80. Fantegrossi, W. E., Ko, M. C., Woods, J. H., and Richelson, E. (2005). Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacol. Biochem. Behav. 80, 341-349. doi: 10.1016/j.pbb.2004.12.005
81. Farrell, M. S., Pei, Y., Wan, Y., Yadav, P. N., Daigle, T. L., Urban, D. J., et al. (2013). A Galphas DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology 38, 854-862. doi: 10.1038/npp.2012.251
82. Fassio, A., Evans, G., Grisshammer, R., Bolam, J. P., Mimmack, M., and Emson, P. C. (2000). Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 39, 1430-1442. doi: 10.1016/S0028-3908(00)00060-5
83. Ferraro, L., Beggiato, S., Tomasini, M. C., Fuxe, K., Tanganelli, S., and Antonelli, T. (2011). Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study. J. Neurosci. Res. 89, 1618-1626. doi: 10.1002/jnr.22686
84. Ferraro, L., O'Connor, W. T., Beggiato, S., Tomasini, M. C., Fuxe, K., Tanganelli, S., et al. (2012). Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release-a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat. Eur. J. Neurosci. 35, 207-220. doi: 10.1111/j.1460-9568.2011.07949.x
85. Ferraro, L., Tomasini, M. C., Mazza, R., Fuxe, K., Fournier, J., Tanganelli, S., et al. (2008). Neurotensin receptors as modulators of glutamatergic transmission. Brain Res. Rev. 58, 365-373. doi: 10.1016/j.brainresrev.2007.11.001
86. File, S. E. (1997). Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol. Biochem. Behav. 58, 747-752. doi: 10.1016/S0091-3057(97)90002-2
87. Fitzpatrick, K., Winrow, C. J., Gotter, A. L., Millstein, J., Arbuzova, J., Brunner, J., et al. (2012). Altered sleep and affect in the neurotensin receptor 1 knockout mouse. Sleep 35, 949-956. doi: 10.5665/sleep.1958
88. Frye, G. D., Luttinger, D., Nemeroff, C. B., Vogel, R. A., Prange, A. J. Jr., and Breese, G. R. (1981). Modification of the actions of ethanol by centrally active peptides. Peptides 2(Suppl. 1), 99-106. doi: 10.1016/0196-9781(81)90063-2
89. Furness, J. B., Hunne, B., Matsuda, N., Yin, L., Russo, D., Kato, I., et al. (2011). Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 193, 1-9. doi: 10.1016/j.neuroscience.2011.07.063
90. Furudono, Y., Ando, C., Yamamoto, C., Kobashi, M., and Yamamoto, T. (2006). Involvement of specific orexigenic neuropeptides in sweetener-induced overconsumption in rats. Behav. Brain Res. 175, 241-248. doi: 10.1016/j.bbr.2006.08.031
91. Gadd, C. A., Murtra, P., De Felipe, C., and Hunt, S. P. (2003). Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J. Neurosci. 23, 8271-8280.
92. Gehle, V. M., and Erwin, V. (1998). Common quantitative trait loci for alcohol-related behaviors and CNS neurotensin measures: voluntary ethanol consumption. Alcohol. Clin. Exp. Res. 22, 401-408. doi: 10.1111/j.1530-0277.1998.tb03666.x
93. Gehlert, D. R., and Gackenheimer, S. L. (1997). Differential distribution of neuropeptide Y Y1 and Y2 receptors in rat and guinea-pig brains. Neuroscience 76, 215-224. doi: 10.1016/S0306-4522(96)00340-5
94. George, D. T., Gilman, J., Hersh, J., Thorsell, A., Herion, D., Geyer, C., et al. (2008). Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319, 1536-1539. doi: 10.1126/science.1153813
95. Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl-Hartmann, C., Smith, K. E., et al. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168-171. doi: 10.1038/382168a0
96. Gerald, C., Walker, M. W., Vaysse, P. J., He, C., Branchek, T. A., and Weinshank, R. L. (1995). Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 270, 26758-26761. doi: 10.1074/jbc.270.45.26758
97. Gessa, G. L., Muntoni, F., Collu, M., Vargiu, L., and Mereu, G. (1985). Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348, 201-203. doi: 10.1016/0006-8993(85)90381-6
98. Gilman, J. M., Ramchandani, V. A., Davis, M. B., Bjork, J. M., and Hommer, D. W. (2008). Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J. Neurosci. 28, 4583-4591. doi: 10.1523/JNEUROSCI.0086-08.2008
99. Gilpin, N. W., Misra, K., Herman, M. A., Cruz, M. T., Koob, G. F., and Roberto, M. (2011). Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biol. Psychiatry 69, 1091-1099. doi: 10.1016/j.biopsych.2011.02.004
100. Gilpin, N. W., Misra, K., and Koob, G. F. (2008). Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol. Biochem. Behav. 90, 475-480. doi: 10.1016/j.pbb.2008.04.006
101. Gilpin, N. W., Stewart, R. B., Murphy, J. M., Li, T. K., and Badia-Elder, N. E. (2003). Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. Alcohol. Clin. Exp. Res. 27, 787-794. doi: 10.1097/01.ALC.0000065723.93234.1D
102. Gnanapavan, S., Kola, B., Bustin, S. A., Morris, D. G., McGee, P., Fairclough, P., et al. (2002). The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87, 2988. doi: 10.1210/jcem.87.6.8739
103. Goldbloom, D. S., Naranjo, C. A., Bremner, K. E., and Hicks, L. K. (1992). Eating disorders and alcohol abuse in women. Br. J. Addict. 87, 913-919. doi: 10.1111/j.1360-0443.1992.tb01986.x
104. Goldstein, D. B. (1972). Relationship of alcohol dose to intensity of withdrawal signs in mice. J. Pharm. Exp. Ther. 180, 203-215.
105. Graham, D., Erreger, K., Galli, A., and Stanwood, G. (2012). GLP-1 analog attenuates cocaine reward. Mol. Psychiatry 18, 961-962. doi: 10.1038/mp.2012.141
106. Gray, T. S., and Morley, J. E. (1986). Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38, 389-401. doi: 10.1016/0024-3205(86)90061-5
107. Graybiel, A. M. (2000). The basal ganglia. Curr. Biol. 10, R509-R511. doi: 10.1016/S0960-9822(00)00593-5
108. Greber, S., Schwarzer, C., and Sperk, G. (1994). Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113, 737-740. doi: 10.1111/j.1476-5381.1994.tb17055.x
109. Groenewegen, H. J., Wright, C. I., and Beijer, A. V. (1996). The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog. Brain Res. 107, 485-511. doi: 10.1016/S0079-6123(08)61883-X
110. Guan, X. M., Yu, H., Palyha, O. C., McKee, K. K., Feighner, S. D., Sirinathsinghji, D. J., et al. (1997). Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48, 23-29. doi: 10.1016/S0169-328X(97)00071-5
111. Gupta, S., and Warner, J. (2008). Alcohol-related dementia: a 21st-century silent epidemic? Br. J Psychiatry 193, 351-353. doi: 10.1192/bjp.bp.108.051425
112. Hansen, L., Deacon, C. F., Orskov, C., and Holst, J. J. (1999). Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140, 5356-5363. doi: 10.1210/endo.140.11.7143
113. Hayes, M. R., Bradley, L., and Grill, H. J. (2009). Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 150, 2654-2659. doi: 10.1210/en.2008-1479
114. Heilig, M., McLeod, S., Brot, M., Heinrichs, S. C., Menzaghi, F., Koob, G. F., et al. (1993). Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8, 357-363. doi: 10.1038/npp.1993.35
115. Herpfer, I., and Lieb, K. (2005). Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19, 275-293. doi: 10.2165/00023210-200519040-00001
116. Hill, R. (2000). NK1 (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol. Sci. 21, 244-246. doi: 10.1016/S0165-6147(00)01502-9
117. Hinton, D. J., Lee, M. R., Jacobson, T. L., Mishra, P. K., Frye, M. A., Mrazek, D. A., et al. (2012). Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1. Neuropharmacology 62, 2480-2488. doi: 10.1016/j.neuropharm.2012.02.022
118. Holst, B., Cygankiewicz, A., Jensen, T. H., Ankersen, M., and Schwartz, T. W. (2003). High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol. Endocrinol. 17, 2201-2210. doi: 10.1210/me.2003-0069
119. Huston, J. P., and Hasenohrl, R. U. (1995). The role of neuropeptides in learning: focus on the neurokinin substance P. Behav. Brain Res. 66, 117-127. doi: 10.1016/0166-4328(94)00132-Y
120. Hwa, L. S., Chu, A., Levinson, S. A., Kayyali, T. M., Debold, J. F., and Miczek, K. A. (2011). Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol. Clin. Exp. Res. 35, 1938-1947. doi: 10.1111/j.1530-0277.2011.01545.x
121. Hwang, B. H., Zhang, J. K., Ehlers, C. L., Lumeng, L., and Li, T. K. (1999). Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol. Clin. Exp. Res. 23, 1023-1030. doi: 10.1111/j.1530-0277.1999.tb04220.x
122. Isacson, R., Nielsen, E., Dannaeus, K., Bertilsson, G., Patrone, C., Zachrisson, O., et al. (2011). The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. Eur. J. Pharmacol. 650, 249-255. doi: 10.1016/j.ejphar.2010.10.008
123. Jerlhag, E. (2008). PRECLINICAL STUDY: systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict. Biol. 13, 358-363. doi: 10.1111/j.1369-1600.2008.00125.x
124. Jerlhag, E., Egecioglu, E., Dickson, S. L., Andersson, M., Svensson, L., and Engel, J. A. (2006). Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict. Biol. 11, 45-54. doi: 10.1111/j.1369-1600.2006.00002.x
125. Jerlhag, E., Egecioglu, E., Dickson, S. L., Douhan, A., Svensson, L., and Engel, J. A. (2007). Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 12, 6-16. doi: 10.1111/j.1369-1600.2006.00041.x
126. Jerlhag, E., Egecioglu, E., Dickson, S. L., and Engel, J. A. (2010). Ghrelin receptor antagonism attenuates cocaine-and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 211, 415-422. doi: 10.1007/s00213-010-1907-7
127. Jerlhag, E., Egecioglu, E., Dickson, S. L., and Engel, J. A. (2011a). Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict. Biol. 16, 82-91. doi: 10.1111/j.1369-1600.2010.00231.x
128. Jerlhag, E., Egecioglu, E., Dickson, S. L., Svensson, L., and Engel, J. A. (2008). Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur. Neuropsychopharmacol. 18, 508-518. doi: 10.1016/j.euroneuro.2008.02.006
129. Jerlhag, E., Egecioglu, E., Landgren, S., Salomé, N., Heilig, M., Moechars, D., et al. (2009). Requirement of central ghrelin signaling for alcohol reward. Proc. Natl. Acad. Sci. U.S.A. 106, 11318-11323. doi: 10.1073/pnas.0812809106
130. Jerlhag, E., Ivanoff, L., Vater, A., and Engel, J. A. (2014). Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. Alcohol. Clin. Exp. Res. 38, 959-968. doi: 10.1111/acer.12337
131. Jerlhag, E., Landgren, S., Egecioglu, E., Dickson, S. L., and Engel, J. A. (2011b). The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice. Alcohol 45, 341-347. doi: 10.1016/j.alcohol.2010.10.002
132. Jomphe, C., Lemelin, P. L., Okano, H., Kobayashi, K., and Trudeau, L. E. (2006). Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons. Eur. J. Neurosci. 24, 2789-2800. doi: 10.1111/j.1460-9568.2006.05151.x
133. Kalivas, P. W., and Duffy, P. (1990). Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10, 2940-2949.
134. Kampov-Polevoy, A., Tsoi, M., Zvartau, E., Neznanov, N., and Khalitov, E. (2001). Sweet liking and family history of alcoholism in hospitalized alcoholic and non-alcoholic patients. Alcohol Alcohol. 36, 165-170. doi: 10.1093/alcalc/36.2.165
135. Kampov-Polevoy, A. B., Garbutt, J. C., and Khalitov, E. (2003). Family history of alcoholism and response to sweets. Alcohol. Clin. Exp. Res. 27, 1743-1749. doi: 10.1097/01.ALC.0000093739.05809.DD
136. Kang-Park, M., Kieffer, B. L., Roberts, A. J., Siggins, G. R., and Moore, S. D. (2013). kappa-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites. J. Pharmacol. Exp. Ther. 346, 130-137. doi: 10.1124/jpet.112.202903
137. Kanoski, S. E., Fortin, S. M., Ricks, K. M., and Grill, H. J. (2013). Ghrelin signaling in the ventral hippocampus stimulates learned and motivational aspects of feeding via PI3K-Akt signaling. Biol. Psychiatry 73, 915-923. doi: 10.1016/j.biopsych.2012.07.002
138. Karagiannides, I., Torres, D., Tseng, Y. H., Bowe, C., Carvalho, E., Espinoza, D., et al. (2008). Substance P as a novel anti-obesity target. Gastroenterology 134, 747-755. doi: 10.1053/j.gastro.2007.12.032
139. Karvonen, M. K., Pesonen, U., Koulu, M., Niskanen, L., Laakso, M., Rissanen, A., et al. (1998). Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4, 1434-1437. doi: 10.1038/4027
140. Kaur, S., and Ryabinin, A. E. (2010). Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol. Clin. Exp. Res. 34, 1525-1534. doi: 10.1111/j.1530-0277.2010.01237.x
141. Kenny, P. J. (2011). Common cellular and molecular mechanisms in obesity and drug addiction. Nat. Rev. Neurosci. 12, 638-651. doi: 10.1038/nrn3105
142. Kim, D.-J., Yoon, S.-J., Choi, B., Kim, T.-S., Woo, Y. S., Kim, W., et al. (2005). Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol. 40, 76-79. doi: 10.1093/alcalc/agh108
143. King, A. C., de Wit, H., McNamara, P. J., and Cao, D. (2011). Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch. Gen. Psychiatry 68, 389-399. doi: 10.1001/archgenpsychiatry.2011.26
144. King, P. J., Widdowson, P. S., Doods, H. N., and Williams, G. (1999). Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J. Neurochem. 73, 641-646. doi: 10.1046/j.1471-4159.1999.0730641.x
145. Kinkead, B., and Nemeroff, C. (2006). Novel treatments of schizophrenia: targeting the neurotensin system. CNS Neurol. Disord. Drug Targets 5, 205-218. doi: 10.2174/187152706776359655
146. Kinkead, B., and Nemeroff, C. B. (2004). Neurotensin, schizophrenia, and antipsychotic drug action. Int. Rev. Neurobiol. 59, 327-349. doi: 10.1016/S0074-7742(04)59013-X
147. Kinzig, K. P., D'Alessio, D. A., Herman, J. P., Sakai, R. R., Vahl, T. P., Figueiredo, H. F., et al. (2003). CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J. Neurosci. 23, 6163-6170.
148. Kleczkowska, P., and Lipkowski, A. W. (2013). Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation-a review. Eur. J. Pharmacol. 716, 54-60. doi: 10.1016/j.ejphar.2013.03.004
149. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660. doi: 10.1038/45230
150. Koob, G. F. (2013). Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr. Top Behav. Neurosci. 13, 3-30. doi: 10.1007/978-3-642-28720-6_129
151. Koob, G. F., and Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238. doi: 10.1038/npp.2009.110
152. Koopmann, A., von der Goltz, C., Grosshans, M., Dinter, C., Vitale, M., Wiedemann, K., et al. (2012). The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology 37, 980-986. doi: 10.1016/j.psyneuen.2011.11.005
153. Kornetsky, C. (1985). Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Res. Monogr. 62, 30-50.
154. Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., and Brown, R. E. (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23, 7-11.
155. Koschatzky, S., and Gmeiner, P. (2012). Selective agonists for dopamine/neurotensin receptor heterodimers. ChemMedChem 7, 509-514. doi: 10.1002/cmdc.201100499
156. Koschatzky, S., Tschammer, N., and Gmeiner, P. (2011). Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics. ACS Chem. Neurosci.2, 308-316. doi: 10.1021/cn200020y
157. Kraus, T., Schanze, A., Gröschl, M., Bayerlein, K., Hillemacher, T., Reulbach, U., et al. (2005). Ghrelin levels are increased in alcoholism. Alcohol. Clin. Exp. Res. 29, 2154-2157. doi: 10.1097/01.alc.0000191753.82554.7e
158. Kufahl, P. R., Zavala, A. R., Singh, A., Thiel, K. J., Dickey, E. D., Joyce, J. N., et al. (2009). c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues. Synapse 63, 823-835. doi: 10.1002/syn.20666
159. Kwako, L. E., George, D. T., Schwandt, M. L., Spagnolo, P. A., Momenan, R., Hommer, D. W., et al. (2014). The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study. Psychopharmacology. doi: 10.1007/s00213-014-3665-4. [Epub ahead of print].
160. Landgren, S., Engel, J. A., Hyytia, P., Zetterberg, H., Blennow, K., and Jerlhag, E. (2011). Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav. Brain Res. 221, 182-188. doi: 10.1016/j.bbr.2011.03.003
161. Landgren, S., Jerlhag, E., Hallman, J., Oreland, L., Lissner, L., Strandhagen, E., et al. (2010). Genetic variation of the ghrelin signaling system in females with severe alcohol dependence. Alcohol. Clin. Exp. Res. 34, 1519-1524. doi: 10.1111/j.1530-0277.2010.01236.x
162. Landgren, S., Jerlhag, E., Zetterberg, H., Gonzalez-Quintela, A., Campos, J., Olofsson, U., et al. (2008). Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass. Alcohol. Clin. Exp. Res. 32, 2054-2061. doi: 10.1111/j.1530-0277.2008.00793.x
163. Landgren, S., Simms, J. A., Hyytiä, P., Engel, J. A., Bartlett, S. E., and Jerlhag, E. (2012). Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict. Biol. 17, 86-94. doi: 10.1111/j.1369-1600.2010.00280.x
164. Lappalainen, J., Kranzler, H. R., Malison, R., Price, L. H., Van Dyck, C., Rosenheck, R. A., et al. (2002). A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 59, 825-831. doi: 10.1001/archpsyc.59.9.825
165. Lee, M. R., Hinton, D. J., Song, J. Y., Lee, K. W., Choo, C., Johng, H., et al. (2010). Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice. Pharmacol. Biochem. Behav. 95, 235-241. doi: 10.1016/j.pbb.2010.01.012
166. Lee, M. R., Hinton, D. J., Unal, S. S., Richelson, E., and Choi, D. S. (2011). Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2. Alcohol. Clin. Exp. Res. 35, 99-107. doi: 10.1111/j.1530-0277.2010.01326.x
167. Leggio, L., Addolorato, G., Cippitelli, A., Jerlhag, E., Kampov-Polevoy, A. B., and Swift, R. M. (2011). Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol. Clin. Exp. Res. 35, 194-202. doi: 10.1111/j.1530-0277.2010.01334.x
168. Leggio, L., Ferrulli, A., Cardone, S., Nesci, A., Miceli, A., Malandrino, N., et al. (2012). Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict. Biol. 17, 452-464. doi: 10.1111/j.1369-1600.2010.00308.x
169. Leggio, L., Schwandt, M. L., Oot, E. N., Dias, A. A., and Ramchandani, V. A. (2013). Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study. Psychoneuroendocrinology 38, 3085-3091. doi: 10.1016/j.psyneuen.2013.09.005
170. Lessard, A., and Pickel, V. M. (2005). Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Neuroscience 135, 1309-1323. doi: 10.1016/j.neuroscience.2005.07.025
171. Li, T. K., Lumeng, L., and Doolittle, D. P. (1993). Selective breeding for alcohol preference and associated responses. Behav. Genet. 23, 163-170. doi: 10.1007/BF01067421
172. Li, T. K., Lumeng, L., McBride, W. J., and Waller, M. B. (1979). Progress toward a voluntary oral consumption model of alcoholism. Drug Alcohol Depend. 4, 45-60. doi: 10.1016/0376-8716(79)90040-1
173. Li, X. M., Ferraro, L., Tanganelli, S., O'Connor, W. T., Hasselrot, U., Ungerstedt, U., et al. (1995). Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study. J. Neural Transm. Gen. Sect. 102, 125-137. doi: 10.1007/BF01276508
174. Li, Z., Boules, M., and Richelson, E. (2011). NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse. Neurosci. Lett. 487, 322-324. doi: 10.1016/j.neulet.2010.10.048
175. Liang, T., Kimpel, M. W., McClintick, J. N., Skillman, A. R., McCall, K., Edenberg, H. J., et al. (2010). Candidate genes for alcohol preference identified by expression profiling in alcohol-preferring and -nonpreferring reciprocal congenic rats. Genome Biol. 11:R11. doi: 10.1186/gb-2010-11-2-r11
176. Lobo, M. K., and Nestler, E. J. (2011). The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front. Neuroanat. 5:41. doi: 10.3389/fnana.2011.00041
177. Lovinger, D. M., White, G., and Weight, F. F. (1989). Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243, 1721-1724. doi: 10.1126/science.2467382
178. Luttinger, D., Frye, G. D., Nemeroff, C. B., and Prange, A. J. Jr. (1983). The effects of neurotensin, beta-endorphin, and bombesin on ethanol-induced behaviors in mice. Psychopharmacology (Berl.) 79, 357-363. doi: 10.1007/BF00433418
179. Lyons, A. M., Lowery, E. G., Sparta, D. R., and Thiele, T. E. (2008). Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol. Clin. Exp. Res. 32, 1962-1968. doi: 10.1111/j.1530-0277.2008.00784.x
180. Ma, H., Huang, Y. L., Zhang, B., Wang, Y., Zhao, H., Du, H., et al. (2013). Association between neurotensin receptor 1 gene polymorphisms and alcohol dependence in a male Han Chinese population. J. Mol. Neurosci. 51, 408-415. doi: 10.1007/s12031-013-0041-5
181. Malik, S., McGlone, F., Bedrossian, D., and Dagher, A. (2008). Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 7, 400-409. doi: 10.1016/j.cmet.2008.03.007
182. Manberg, P. J., Youngblood, W. W., Nemeroff, C. B., Rossor, M. N., Iversen, L. L., Prange, A. J. Jr., et al. (1982). Regional distribution of neurotensin in human brain. J. Neurochem. 38, 1777-1780. doi: 10.1111/j.1471-4159.1982.tb06664.x
183. Mantyh, P. W., Hunt, S. P., and Maggio, J. E. (1984). Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res. 307, 147-165. doi: 10.1016/0006-8993(84)90470-0
184. Marinelli, P. W., Funk, D., Juzytsch, W., Harding, S., Rice, K. C., Shaham, Y., et al. (2007). The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 195, 345-355. doi: 10.1007/s00213-007-0905-x
185. Matsumoto, M., Nomura, T., Momose, K., Ikeda, Y., Kondou, Y., Akiho, H., et al. (1996). Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 271, 27217-27220. doi: 10.1074/jbc.271.44.27217
186. Mayfield, R. D., Lewohl, J. M., Dodd, P. R., Herlihy, A., Liu, J., and Harris, R. A. (2002). Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J. Neurochem. 81, 802-813. doi: 10.1046/j.1471-4159.2002.00860.x
187. Mazella, J., Botto, J.-M., Guillemare, E., Coppola, T., Sarret, P., and Vincent, J.-P. (1996). Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 16, 5613-5620.
188. McDonald, A. J. (1998). Cortical pathways to the mammalian amygdala. Prog. Neurobiol. 55, 257-332. doi: 10.1016/S0301-0082(98)00003-3
189. McDonald, A. J., and Pearson, J. C. (1989). Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci. Lett. 100, 53-58. doi: 10.1016/0304-3940(89)90659-9
190. McFarland, K., Davidge, S. B., Lapish, C. C., and Kalivas, P. W. (2004). Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24, 1551-1560. doi: 10.1523/JNEUROSCI.4177-03.2004
191. McFarland, K., and Kalivas, P. W. (2001). The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 21, 8655-8663.
192. Merchenthaler, I. (1991). Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold. Neuroscience 44, 655-662. doi: 10.1016/0306-4522(91)90085-3
193. Merchenthaler, I., Lane, M., and Shughrue, P. (1999). Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403, 261-280. doi: 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
194. Metten, P., and Crabbe, J. C. (2005). Alcohol withdrawal severity in inbred mouse (Mus musculus) strains. Behav. Neurosci. 119, 911-925. doi: 10.1037/0735-7044.119.4.911
195. Michel, M. C. (1991). Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12, 389-394. doi: 10.1016/0165-6147(91)90610-5
196. Mietlicki-Baase, E. G., Ortinski, P. I., Reiner, D. J., Sinon, C. G., McCutcheon, J. E., Pierce, R. C., et al. (2014). Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling. J. Neurosci. 34, 6985-6992. doi: 10.1523/JNEUROSCI.0115-14.2014
197. Mietlicki-Baase, E. G., Ortinski, P. I., Rupprecht, L. E., Olivos, D. R., Alhadeff, A. L., Pierce, R. C., et al. (2013). The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am. J. Physiol. Endocrinol. Metab. 305, E1367-E1374. doi: 10.1152/ajpendo.00413.2013
198. Minabe, Y., Emori, K., Toor, A., Stutzmann, G. E., and Ashby, C. R. Jr. (1996). The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse 22, 35-45. doi: 10.1002/(SICI)1098-2396(199601)22:1<35::AID-SYN4>3.0.CO;2-J
199. Mitrovic, I., and Napier, T. C. (1998). Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum. Brain Res. 792, 193-206. doi: 10.1016/S0006-8993(98)00130-9
200. Moghaddam, B., and Bolinao, M. L. (1994). Biphasic effect of ethanol on extracellular accumulation of glutamate in the hippocampus and the nucleus accumbens. Neurosci. Lett. 178, 99-102. doi: 10.1016/0304-3940(94)90299-2
201. Mohler, H. (2012). The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62, 42-53. doi: 10.1016/j.neuropharm.2011.08.040
202. Moller, C., Wiklund, L., Sommer, W., Thorsell, A., and Heilig, M. (1997). Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760, 94-101. doi: 10.1016/S0006-8993(97)00308-9
203. Moore, E. M., Mariani, J. N., Linsenbardt, D. N., Melon, L. C., and Boehm, S. L. 2nd. (2010). Adolescent C57BL/6J (but not DBA/2J) mice consume greater amounts of limited-access ethanol compared to adults and display continued elevated ethanol intake into adulthood. Alcohol. Clin. Exp. Res. 34, 734-742. doi: 10.1111/j.1530-0277.2009.01143.x
204. Murtra, P., Sheasby, A. M., Hunt, S. P., and De Felipe, C. (2000). Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405, 180-183. doi: 10.1038/35012069
205. Nakaya, Y., Kaneko, T., Shigemoto, R., Nakanishi, S., and Mizuno, N. (1994). Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347, 249-274. doi: 10.1002/cne.903470208
206. Naleid, A. M., Grace, M. K., Cummings, D. E., and Levine, A. S. (2005). Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26, 2274-2279. doi: 10.1016/j.peptides.2005.04.025
207. Napier, T. C., Mitrovic, I., Churchill, L., Klitenick, M. A., Lu, X. Y., and Kalivas, P. W. (1995). Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 69, 59-70. doi: 10.1016/0306-4522(95)00218-8
208. Naqvi, N. H., and Bechara, A. (2009). The hidden island of addiction: the insula. Trends Neurosci. 32, 56-67. doi: 10.1016/j.tins.2008.09.009
209. Naslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J. E., Holst, J. J., et al. (1999). Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 23, 304-311. doi: 10.1038/sj.ijo.0800818
210. Nemeroff, C. B., Bissette, G., Prange, A. J. Jr., Loosen, P. T., Barlow, T. S., and Lipton, M. A. (1977). Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res. 128, 485-496. doi: 10.1016/0006-8993(77)90173-1
211. Nguyen, A. D., Mitchell, N. F., Lin, S., Macia, L., Yulyaningsih, E., Baldock, P. A., et al. (2012). Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice. PLoS ONE 7:e40191. doi: 10.1371/journal.pone.0040191
212. Nikolaus, S., Huston, J. P., and Hasenohrl, R. U. (1999). Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. Eur. J. Pharmacol. 370, 93-99. doi: 10.1016/S0014-2999(99)00105-3
213. Pandey, S. C., Zhang, H., Roy, A., and Xu, T. (2005). Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest. 115, 2762-2773. doi: 10.1172/JCI24381
214. Papp, M., Vassout, A., and Gentsch, C. (2000). The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav. Brain Res. 115, 19-23. doi: 10.1016/S0166-4328(00)00230-8
215. Parker, R. M., and Herzog, H. (1999). Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431-1448. doi: 10.1046/j.1460-9568.1999.00553.x
216. Pelaprat, D. (2006). Interactions between neurotensin receptors and G proteins. Peptides 27, 2476-2487. doi: 10.1016/j.peptides.2006.04.027
217. Peltonen, I., Myohanen, T. T., and Mannisto, P. T. (2012). Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways. Neurochem. Res. 37, 2033-2041. doi: 10.1007/s11064-012-0825-y
218. Perello, M., Sakata, I., Birnbaum, S., Chuang, J. C., Osborne-Lawrence, S., Rovinsky, S. A., et al. (2010). Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol. Psychiatry 67, 880-886. doi: 10.1016/j.biopsych.2009.10.030
219. Perfetti, R., and Merkel, P. (2000). Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function. Eur. J. Endocrinol. 143, 717-725. doi: 10.1530/eje.0.1430717
220. Perry, T., Lahiri, D. K., Chen, D., Zhou, J., Shaw, K. T., Egan, J. M., et al. (2002). A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J. Pharmacol. Exp. Ther. 300, 958-966. doi: 10.1124/jpet.300.3.958
221. Petkova-Kirova, P., Rakovska, A., Della Corte, L., Zaekova, G., Radomirov, R., and Mayer, A. (2008a). Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis. Brain Res. Bull. 77, 129-135. doi: 10.1016/j.brainresbull.2008.04.003
222. Petkova-Kirova, P., Rakovska, A., Zaekova, G., Ballini, C., Corte, L. D., Radomirov, R., et al. (2008b). Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders. Neurochem. Int. 53, 355-361. doi: 10.1016/j.neuint.2008.08.010
223. Primeaux, S. D., Wilson, S. P., Bray, G. A., York, D. A., and Wilson, M. A. (2006). Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. Alcohol. Clin. Exp. Res. 30, 791-801. doi: 10.1111/j.1530-0277.2006.00092.x
224. Prut, L., and Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463, 3-33. doi: 10.1016/S0014-2999(03)01272-X
225. Ramalho, R., Almeida, J., Beltrao, M., Pirraco, A., Costa, R., Sokhatska, O., et al. (2013). Substance P antagonist improves both obesity and asthma in a mouse model. Allergy 68, 48-54. doi: 10.1111/all.12052
226. Reddy, I. A., Stanwood, G. D., and Galli, A. (2013). Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochem. Int. 73, 49-55. doi: 10.1016/j.neuint.2013.10.003
227. Reep, R. L., and Winans, S. S. (1982). Efferent connections of dorsal and ventral agranular insular cortex in the hamster, Mesocricetus auratus. Neuroscience 7, 2609-2635. doi: 10.1016/0306-4522(82)90087-2
228. Reyneke, L., Russell, V. A., and Taljaard, J. J. (1990). Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation. Brain Res. 534, 188-194. doi: 10.1016/0006-8993(90)90128-X
229. Rhodes, J. S., Best, K., Belknap, J. K., Finn, D. A., and Crabbe, J. C. (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 84, 53-63. doi: 10.1016/j.physbeh.2004.10.007
230. Rimondini, R., Thorsell, A., and Heilig, M. (2005). Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci. Lett. 375, 129-133. doi: 10.1016/j.neulet.2004.10.084
231. Ripley, T. L., Gadd, C. A., De Felipe, C., Hunt, S. P., and Stephens, D. N. (2002). Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43, 1258-1268. doi: 10.1016/S0028-3908(02)00295-2
232. Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., and Siggins, G. R. (2003). Ethanol increases GABAergic transmission at both pre-and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U.S.A. 100, 2053-2058. doi: 10.1073/pnas.0437926100
233. Robledo, P., Maldonado, R., and Koob, G. F. (1993). Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622, 105-112. doi: 10.1016/0006-8993(93)90808-Z
234. Rogers, J. L., and See, R. E. (2007). Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol. Learn. Mem. 87, 688-692. doi: 10.1016/j.nlm.2007.01.003
235. Rostene, W. H., and Alexander, M. J. (1997). Neurotensin and neuroendocrine regulation. Front. Neuroendocrinol. 18, 115-173. doi: 10.1006/frne.1996.0146
236. Roy, A., and Pandey, S. C. (2002). The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol. Clin. Exp. Res. 26, 796-803. doi: 10.1111/j.1530-0277.2002.tb02607.x
237. Rupniak, N., Carlson, E., Harrison, T., Oates, B., Seward, E., Owen, S., et al. (2000). Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39, 1413-1421. doi: 10.1016/S0028-3908(00)00052-6
238. Salome, N., Haage, D., Perrissoud, D., Moulin, A., Demange, L., Egecioglu, E., et al. (2009). Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur. J. Pharmacol. 612, 167-173. doi: 10.1016/j.ejphar.2009.03.066
239. Samson, H. H., Pfeffer, A. O., and Tolliver, G. A. (1988). Oral ethanol self-administration in rats: models of alcohol-seeking behavior. Alcohol. Clin. Exp. Res. 12, 591-598. doi: 10.1111/j.1530-0277.1988.tb00248.x
240. Sanchis-Segura, C., and Spanagel, R. (2006). REVIEW: behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 11, 2-38. doi: 10.1111/j.1369-1600.2006.00012.x
241. Santarelli, L., Gobbi, G., Debs, P. C., Sibille, E. L., Blier, P., Hen, R., et al. (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. U.S.A. 98, 1912-1917. doi: 10.1073/pnas.98.4.1912
242. Sarret, P., Perron, A., Stroh, T., and Beaudet, A. (2003). Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J. Comp. Neurol. 461, 520-538. doi: 10.1002/cne.10718
243. Saunders, B. T., and Robinson, T. E. (2012). The role of dopamine in the accumbens core in the expression of Pavlovian-conditioned responses. Eur. J. Neurosci. 36, 2521-2532. doi: 10.1111/j.1460-9568.2012.08217.x
244. Schank, J. R. (2014). The neurokinin-1 receptor in addictive processes. J. Pharmacol. Exp. Ther. 351, 2-8. doi: 10.1124/jpet.113.210799
245. Schank, J. R., King, C. E., Sun, H., Cheng, K., Rice, K. C., Heilig, M., et al. (2014). The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking. Neuropsychopharmacology 39, 1093-1101. doi: 10.1038/npp.2013.309
246. Schank, J. R., Pickens, C. L., Rowe, K. E., Cheng, K., Thorsell, A., Rice, K. C., et al. (2011). Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429. Psychopharmacology 218, 111-119. doi: 10.1007/s00213-011-2201-z
247. Schank, J. R., Tapocik, J. D., Barbier, E., Damadzic, R., Eskay, R. L., Sun, H., et al. (2013). Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats. Biol. Psychiatry 73, 774-781. doi: 10.1016/j.biopsych.2012.12.027
248. Schick, R. R., Zimmermann, J. P., Vorm Walde, T., and Schusdziarra, V. (2003). Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1427-R1435. doi: 10.1152/ajpregu.00479.2002
249. Schneider, E. R., Rada, P., Darby, R. D., Leibowitz, S. F., and Hoebel, B. G. (2007). Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol. Clin. Exp. Res. 31, 1858-1865. doi: 10.1111/j.1530-0277.2007.00510.x
250. Schroeder, J. P., Iller, K. A., and Hodge, C. W. (2003). Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration. Alcohol. Clin. Exp. Res. 27, 1912-1920. doi: 10.1097/01.ALC.0000098873.80433.BA
251. Schroeder, J. P., Overstreet, D. H., and Hodge, C. W. (2005). The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats. Alcohol 36, 179-186. doi: 10.1016/j.alcohol.2005.10.001
252. Seneviratne, C., Ait-Daoud, N., Ma, J. Z., Chen, G., Johnson, B. A., and Li, M. D. (2009). Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence. Neuropsychopharmacology 34, 2442-2449. doi: 10.1038/npp.2009.65
253. Sesack, S. R., and Grace, A. A. (2010). Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology 35, 27-47. doi: 10.1038/npp.2009.93
254. Severini, C., Improta, G., Falconieri-Erspamer, G., Salvadori, S., and Erspamer, V. (2002). The tachykinin peptide family. Pharmacol. Rev. 54, 285-322. doi: 10.1124/pr.54.2.285
255. Sheikh, S. P., Hakanson, R., and Schwartz, T. W. (1989). Y1 and Y2 receptors for neuropeptide Y. FEBS Lett. 245, 209-214. doi: 10.1016/0014-5793(89)80223-6
256. Shirazi, R. H., Dickson, S. L., and Skibicka, K. P. (2013). Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS ONE 8:e61965. doi: 10.1371/journal.pone.0061965
257. Shults, C. W., Quirion, R., Chronwall, B., Chase, T. N., and O'Donohue, T. L. (1984). A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides 5, 1097-1128. doi: 10.1016/0196-9781(84)90177-3
258. Skibicka, K. P. (2013). The central GLP-1: implications for food and drug reward. Front. Neurosci. 7:181. doi: 10.3389/fnins.2013.00181
259. Skibicka, K. P., and Dickson, S. L. (2011). Ghrelin and food reward: the story of potential underlying substrates. Peptides 32, 2265-2273. doi: 10.1016/j.peptides.2011.05.016
260. Skibicka, K. P., Hansson, C., Alvarez-Crespo, M., Friberg, P. A., and Dickson, S. L. (2011). Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 180, 129-137. doi: 10.1016/j.neuroscience.2011.02.016
261. Skibicka, K. P., Hansson, C., Egecioglu, E., and Dickson, S. L. (2012). Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict. Biol. 17, 95-107. doi: 10.1111/j.1369-1600.2010.00294.x
262. Skibicka, K. P., Shirazi, R. H., Rabasa-Papio, C., Alvarez-Crespo, M., Neuber, C., Vogel, H., et al. (2013). Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake. Neuropharmacology 73, 274-283. doi: 10.1016/j.neuropharm.2013.06.004
263. Slawecki, C. J., Jimenéz-Vasquez, P., Mathé, A. A., and Ehlers, C. L. (2001). Substance P and neurokinin levels are decreased in the cortex and hypothalamus of alcohol-preferring (P) rats. J. Stud. Alcohol 62, 736.
264. Slawecki, C. J., Jiménez-Vasquez, P., Mathé, A. A., and Ehlers, C. L. (2005). Effect of ethanol on brain neuropeptides in adolescent and adult rats. J. Stud. Alcohol 66, 46.
265. Sorensen, G., Lindberg, C., Wortwein, G., Bolwig, T. G., and Woldbye, D. P. (2004). Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J. Neurosci. Res. 77, 723-729. doi: 10.1002/jnr.20200
266. Sparrow, A. M., Lowery-Gionta, E. G., Pleil, K. E., Li, C., Sprow, G. M., Cox, B. R., et al. (2012). Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology 37, 1409-1421. doi: 10.1038/npp.2011.327
267. Stafford, D., Lesage, M. G., and Glowa, J. R. (1998). Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139, 169-184. doi: 10.1007/s002130050702
268. Stanic, D., Brumovsky, P., Fetissov, S., Shuster, S., Herzog, H., and Hokfelt, T. (2006). Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J. Comp. Neurol. 499, 357-390. doi: 10.1002/cne.21046
269. Steensland, P., Simms, J. A., Nielsen, C. K., Holgate, J., Bito-Onon, J. J., and Bartlett, S. E. (2010). The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol. PLoS ONE 5:e12527. doi: 10.1371/journal.pone.0012527
270. Stewart, R. B., Gatto, G. J., Lumeng, L., Li, T. K., and Murphy, J. M. (1993). Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 10, 1-10. doi: 10.1016/0741-8329(93)90046-Q
271. Stolakis, V., Kalafatakis, K., Botis, J., Zarros, A., and Liapi, C. (2010). The regulatory role of neurotensin on the hypothalamic-anterior pituitary axons: emphasis on the control of thyroid-related functions. Neuropeptides 44, 1-7. doi: 10.1016/j.npep.2009.09.005
272. Suchankova, P., Steensland, P., Fredriksson, I., Engel, J. A., and Jerlhag, E. (2013). Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS ONE 8:e71284. doi: 10.1371/journal.pone.0071284
273. Sumners, C., Phillips, M. I., and Richards, E. M. (1982). Central pressor action of neurotensin in conscious rats. Hypertension 4, 888-893. doi: 10.1161/01.HYP.4.6.888
274. Sun, Q. Q., Akk, G., Huguenard, J. R., and Prince, D. A. (2001). Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J. Physiol. 531, 81-94. doi: 10.1111/j.1469-7793.2001.0081j.x
275. Szulc, M., Mikolajczak, P. L., Geppert, B., Wachowiak, R., Dyr, W., and Bobkiewicz-Kozlowska, T. (2013). Ethanol affects acylated and total ghrelin levels in peripheral blood of alcohol-dependent rats. Addict. Biol. 18, 689-701. doi: 10.1111/adb.12025
276. Szulc, P., Zgliczyñski, W., Jeske, W., Soszyñski, P., Roslonowska, E., Nowakowski, J., et al. (1991). The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol. Pol. 43, 264-272.
277. Tamiya, R., Hanada, M., Kawai, Y., Inagaki, S., and Takagi, H. (1990). Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci. Lett. 110, 11-15. doi: 10.1016/0304-3940(90)90779-9
278. Tasan, R. O., Nguyen, N. K., Weger, S., Sartori, S. B., Singewald, N., Heilbronn, R., et al. (2010). The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J. Neurosci. 30, 6282-6290. doi: 10.1523/JNEUROSCI.0430-10.2010
279. Tatemoto, K., Carlquist, M., and Mutt, V. (1982). Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296, 659-660. doi: 10.1038/296659a0
280. Teixeira, R. M., Santos, A. R., Ribeiro, S. J., Calixto, J. B., Rae, G. A., and De Lima, T. (1996). Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur. J. Pharmacol. 311, 7-14. doi: 10.1016/0014-2999(96)00390-1
281. Thibault, D., Albert, P. R., Pineyro, G., and Trudeau, L. E. (2011). Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism. J. Biol. Chem. 286, 9174-9184. doi: 10.1074/jbc. M110.166454
282. Thiele, T. E., Koh, M. T., and Pedrazzini, T. (2002). Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 22, RC208.
283. Thiele, T. E., Marsh, D. J., Marie, L. S., Bernstein, I. L., and Palmiter, R. D. (1998). Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366-369. doi: 10.1038/24614
284. Thiele, T. E., Miura, G. I., Marsh, D. J., Bernstein, I. L., and Palmiter, R. D. (2000). Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacol. Biochem. Behav. 67, 683-691. doi: 10.1016/S0091-3057(00)00413-5
285. Thiele, T. E., Naveilhan, P., and Ernfors, P. (2004). Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides 25, 975-983. doi: 10.1016/j.peptides.2004.03.009
286. Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., and Widmann, C. (1993). Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42, 1678-1682. doi: 10.2337/diab.42.11.1678
287. Thorsell, A., Schank, J. R., Singley, E., Hunt, S. P., and Heilig, M. (2010). Neurokinin-1 receptors (NK1R: s), alcohol consumption, and alcohol reward in mice. Psychopharmacology 209, 103-111. doi: 10.1007/s00213-010-1775-1
288. Thorsell, A., Slawecki, C. J., and Ehlers, C. L. (2005a). Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav. Brain Res. 161, 133-140. doi: 10.1016/j.bbr.2005.01.016
289. Thorsell, A., Slawecki, C. J., and Ehlers, C. L. (2005b). Effects of neuropeptide Y on appetitive and consummatory behaviors associated with alcohol drinking in wistar rats with a history of ethanol exposure. Alcohol. Clin. Exp. Res. 29, 584-590. doi: 10.1097/01.ALC.0000160084.13148.02
290. Topple, A. N., Hunt, G. E., and McGregor, I. S. (1998). Possible neural substrates of beer-craving in rats. Neurosci. Lett. 252, 99-102. doi: 10.1016/S0304-3940(98)00574-6
291. Trapp, S., and Hisadome, K. (2011). Glucagon-like peptide 1 and the brain: central actions-central sources? Auton. Neurosci.161, 14-19. doi: 10.1016/j.autneu.2010.09.008
292. Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., et al. (2003). Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur. J. Neurosci. 18, 143-148. doi: 10.1046/j.1460-9568.2003.02725.x
293. Tschöp, M., Smiley, D. L., and Heiman, M. L. (2000). Ghrelin induces adiposity in rodents. Nature 407, 908-913. doi: 10.1038/35038090
294. Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M., Meeran, K., et al. (1996). A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72. doi: 10.1038/379069a0
295. Us, V. E., and Gaddum, J. H. (1931). An unidentified depressor substance in certain tissue extracts. J. Physiol. 72, 74-87.
296. Vadnie, C. A., Hinton, D. J., Choi, S., Choi, Y., Ruby, C. L., Oliveros, A., et al. (2014). Activation of neurotensin receptor type 1 attenuates locomotor activity. Neuropharmacology 85, 482-492. doi: 10.1016/j.neuropharm.2014.05.046
297. Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., et al. (2002). Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 26, 1494-1501. doi: 10.1111/j.1530-0277.2002.tb02448.x
298. Vincent, J.-P., Mazella, J., and Kitabgi, P. (1999). Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20, 302-309. doi: 10.1016/S0165-6147(99)01357-7
299. Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., and Telang, F. (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl. 1), 3-8. doi: 10.1016/j.neuropharm.2008.05.022
300. Volkow, N. D., Wang, G. J., Fowler, J. S., and Tomasi, D. (2012a). Addiction circuitry in the human brain. Annu. Rev. Pharmacol. Toxicol. 52, 321-336. doi: 10.1146/annurev-pharmtox-010611-134625
301. Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., and Baler, R. (2012b). Food and drug reward: overlapping circuits in human obesity and addiction. Curr. Top. Behav. Neurosci. 11, 1-24. doi: 10.1007/7854_2011_169
302. Wachi, M., Fujimaki, M., Nakamura, H., and Inazuki, G. (1996). Effects of ethanol administration on brain neurotensin-like immunoreactivity in rats. Acta Neurol. Scand. 93, 211-214. doi: 10.1111/j.1600-0404.1996.tb00202.x
303. Walker, B. M., Drimmer, D. A., Walker, J. L., Liu, T., Mathe, A. A., and Ehlers, C. L. (2010). Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol 44, 487-493. doi: 10.1016/j.alcohol.2010.06.006
304. Walker, N., Lepee-Lorgeoux, I., Fournier, J., Betancur, C., Rostene, W., Ferrara, P., et al. (1998). Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain. Mol. Brain Res. 57, 193-200. doi: 10.1016/S0169-328X(98)00074-6
305. Wang, R., Boules, M., Tiner, W., and Richelson, E. (2004). Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro. Brain Res. 1025, 21-28. doi: 10.1016/j.brainres.2004.07.069
306. Weiss, F. (2005). Neurobiology of craving, conditioned reward and relapse. Curr. Opin. Pharmcol. 5, 9-19. doi: 10.1016/j.coph.2004.11.001
307. Wetherill, L., Schuckit, M. A., Hesselbrock, V., Xuei, X., Liang, T., Dick, D. M., et al. (2008). Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcohol. Clin. Exp. Res. 32, 2031-2040. doi: 10.1111/j.1530-0277.2008.00790.x
308. Widdowson, P. S. (1993). Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain. Brain Res. 631, 27-38. doi: 10.1016/0006-8993(93)91182-R
309. Wolak, M. L., Dejoseph, M. R., Cator, A. D., Mokashi, A. S., Brownfield, M. S., and Urban, J. H. (2003). Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J. Comp. Neurol. 464, 285-311. doi: 10.1002/cne.10823
310. Woodard, G. A., Downey, J., Hernandez-Boussard, T., and Morton, J. M. (2011). Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J. Am. Coll. Surg. 212, 209-214. doi: 10.1016/j.jamcollsurg.2010.09.020
311. Woolf, N. J. (1991). Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37, 475-524. doi: 10.1016/0301-0082(91)90006-M
312. Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., et al. (2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328. doi: 10.1210/endo.141.11.7873
313. Wurst, F. M., Graf, I., Ehrenthal, H. D., Klein, S., Backhaus, J., Blank, S., et al. (2007). Gender Differences for ghrelin levels in alcohol-dependent patients and differences between alcoholics and healthy controls. Alcohol. Clin. Exp. Res. 31, 2006-2011. doi: 10.1111/j.1530-0277.2007.00527.x
314. Yang, A. R., Yi, H. S., Mamczarz, J., June, H. L. Jr., Hwang, B. H., and June, H. L. Sr. (2009). Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding. Synapse 63, 972-981. doi: 10.1002/syn.20677
315. Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008). Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396. doi: 10.1016/j.cell.2008.01.017
316. Yin, H. H., and Knowlton, B. J. (2006). The role of the basal ganglia in habit formation. Nat. Rev. Neurosci. 7, 464-476. doi: 10.1038/nrn1919
317. Young, A. A., Gedulin, B., Bhavsar, S., Bodkin, N., Jodka, C., Hansen, B., et al. (1999). Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48, 1026-1034. doi: 10.2337/diabetes.48.5.1026
318. Yousseif, A., Emmanuel, J., Karra, E., Millet, Q., Elkalaawy, M., Jenkinson, A. D., et al. (2014). Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes. Surg. 24, 241-252. doi: 10.1007/s11695-013-1066-0
319. Zhao, Z., Yang, Y., Walker, D. L., and Davis, M. (2009). Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology 34, 331-340. doi: 10.1038/npp.2008.55
320. Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., and Elmquist, J. K. (2006). Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 494, 528-548. doi: 10.1002/cne.20823
321. Zimmermann, U. S., Buchmann, A., Steffin, B., Dieterle, C., and Uhr, M. (2007). CLINICAL STUDY: alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addict. Biol. 12, 17-21. doi: 10.1111/j.1369-1600.2006.00026.x